Facilitated By

San Antonio Medical Foundation

Trending Research

Top viewed research performed by San Antonio Bioscience Organizations


The overall objective is to establish the safety and efficacy of GR-MD-02 in patients with moderate to severe plaque psoriasis<p>Primary Objective - The objective is to evaluate the number of patients with moderate to severe plaque psoriasis who have 75% improvement in Psoriasis Activity Severity Index (PASI-75) following 12 weeks of therapy with GR-MD-02</p><p>Secondary Objectives - </p><p>To determine the PASI-50 and PASI-100 scores in patients with moderate to severe plaque psoriasis following the first 12 weeks of therapy with GR-MD-02</p><p>To

Brooke Army Medical Center
Email for information